NCT04295486View on ClinicalTrials.gov

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

PHASE2RecruitingINTERVENTIONAL

Enrollment

5,478

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Venous Thromboembolism

Interventions

DRUG

Aspirin

Non-enteric coated 81 mg Aspirin tablet.

Trial Locations (1)

33136

RECRUITING

University of Miami Hospital, Miami

All Listed Sponsors

lead

University of Miami

OTHER